Parexel Recognized by Frost & Sullivan with 2022 Global Customer Value Leadership Award
Frost & Sullivan
OCTOBER 14, 2022
SAN ANTONIO, TX. – Oct. 14, 2022 – Based on its recent analysis of the global decentralized clinical trials (DCT) industry, Frost & Sullivan has recognized leading global clinical research organization (CRO) Parexel with the 2022 Global Customer Value Leadership Award. Parexel combines in-house expertise, patient and caregiver insights, and cutting-edge technologies to plan, operationalize, and deliver DCTs for biopharmaceutical customers worldwide while ensuring the highest levels of patien
Let's personalize your content